in this issue
Services :: Financial
Cytec earnings decline, but beat estimates
4:57 PM MST | January 30, 2014 | Vincent Valk
Cytec today reported adjusted earnings from continuing operations down 3.5% year-on-year (YOY), to $41.9 million, on sales up 1.9%, to $480 million. Actual earnings totaled $59.4 million, or $1.62/share. Adjusted earnings totaled $1.15/share, beating analysts' consensus estimate of $1.11/share, as reported by Thomson Reuters (New York). “Each business segment delivered sales growth versus the prior year period excluding 2012 sales from the divested distribution product line. The specialty chemical segments provided solid earnings performance and industrial...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee